Despite a dismal long-term performance, Sirius XM (SIRI) is showing curious resilience in the new year. A complex volatility skew in its options suggests traders are bracing for a potential surprise—in either direction—as the company prepares to report quarterly results.
Elon Musk is reportedly in advanced discussions to merge his space exploration giant, SpaceX, with his artificial intelligence venture, xAI, in a move that could reshape the frontiers of both industries and delay SpaceX's anticipated public offering.
Amid surging government revenue and public protests over its ICE contracts, Palantir CEO Alex Karp defends the company's controversial surveillance technology, framing it as a safeguard against state overreach rather than an enabler.
Market momentum, technical indicators, and sustained capital inflows are aligning to potentially propel RAIN, KITE, and STABLE to new all-time highs in early February, though analysts caution over key resistance levels.
The United States and India have announced a significant trade agreement, dramatically reducing tariffs after months of tension. The deal, linked to India halting Russian oil purchases, aims to boost bilateral trade and supply chain diversification.
Cotton futures trimmed early losses by midday Thursday, recovering slightly despite broader market pressure. The partial rebound followed a surprise announcement from former President Donald Trump regarding a new trade agreement with India, a key cotton importer.
As the energy sector leads the market in early 2026, ConocoPhillips and Kinder Morgan emerge as compelling picks for investors seeking reliable, growing dividends backed by strong fundamentals and strategic positioning.
While Broadcom rides a massive wave of AI demand, investor concerns over shrinking profitability have triggered a significant pullback in its shares, presenting a classic growth-versus-margin dilemma.
TD Cowen and H.C. Wainwright have raised price targets on KalVista Pharmaceuticals, expressing confidence in its oral hereditary angioedema treatment ahead of the company's fourth-quarter financial results.
Clinical-stage biotech Erasca (ERAS) has seen its stock skyrocket over the past 12 months, hitting a multi-year high. While technical momentum is strong, the company remains pre-revenue, with its fate tied to future drug approvals, presenting a classic high-risk, high-reward scenario for investors.
New clinical imaging data for Molecular Partners' experimental radiotherapeutic MP0712, targeting the DLL3 protein in cancers like small cell lung cancer, show favorable tumor targeting and healthy organ clearance. The company confirms its U.S. Phase I/II trial is now open for patient screening.
A broad sell-off in risk assets, from equities to precious metals, has triggered over $2.5 billion in Bitcoin liquidations. Analysts point to shifting Federal Reserve expectations and AI trade anxieties as key drivers behind the latest crypto market tremor.
CNBC's Jim Cramer endorsed Carrier Global Corp. (NYSE:CARR) on his recent show, praising CEO Dave Gitlin's leadership and strategic acquisition. He recommended investors buy the stock for the long term, citing confidence in the company's positioning within the climate solutions sector.
CNBC's Jim Cramer concedes he misjudged the explosive demand for Apple's iPhone 17, which powered the tech giant to a staggering earnings beat that caught Wall Street off guard.
AbbVie's stock presents a complex picture for investors, with recent mixed performance contrasting sharply with its robust multi-year returns. As shares trade below consensus targets, the market weighs near-term headwinds against the pharmaceutical giant's proven track record and pipeline potential.
Dropbox shares have faced significant pressure over the past year, declining roughly 20% and raising questions about its long-term growth trajectory. As the stock trades below key fair value estimates, investors are divided on whether this represents a buying opportunity or reflects deeper challenges in the competitive cloud storage market.
Amid a volatile market backdrop, several ASX-listed companies, including gold miner Capricorn Metals, are flagged as potentially trading significantly below their intrinsic value, presenting opportunities for discerning investors.
Sportradar Group's (SRAD) shares have tumbled over 20% in the past month, pushing the sports data giant back into the spotlight. With a stark disconnect between its current price and some bullish fair value estimates, investors are debating whether this is a moment of weakness or a warning signal.
Financial guru Suze Orman's blunt critique of auto leasing has reignited the buy-vs-lease debate, revealing deep divides in consumer financial strategy as industry data shows persistent leasing popularity despite economic headwinds.
Bitcoin clawed back some of its steep weekend losses in Monday trading, though the broader digital asset sector and related equities remained under significant selling pressure as investors digested a wave of forced liquidations and awaited key U.S. economic data.
